POET Technologies Inc. - CEO, Dr. Suresh Venkatesan.
CEO, Dr. Suresh Venkatesan.
Source: POET Technologies.
  • POET Technologies (PTK) announced a non-brokered private placement for gross proceeds of up to C$6.85 million
  • The corporation will issue up to 1,798,561 units at $3.81 per unit
  • The offering is expected to close on or around December 2, 2022
  • POET Technologies is a design and development company
  • POET Technologies Inc. (PTK) is down 2.13 per cent on the day, trading at C$3.68 per share at 2:30 pm ET

POET Technologies (PTK) announced a non-brokered private placement for gross proceeds of up to C$6.85 million.

The corporation will issue up to 1,798,561 units at $3.81 per unit. Each unit will consist of one common share and one-half of one common share purchase warrant. Each whole warrant entitles the holder to purchase one additional share at a price of C$4.95 for a period of three years following the closing date of the offering. The net proceeds will be used for general corporate purposes.

POET has entered into subscription agreements with investors representing expected subscription proceeds totalling approximately C$3.75 million. The corporation may accept subscriptions from other investors up to a total of approximately C$6.85 million.

The offering is expected to close on or around December 2, 2022. 

All securities issued will be subject to a statutory four-month hold period. POET may pay cash commissions and or finder’s fees in connection with the offering.

POET Technologies is a design and development company offering integrated solutions based on the POET Optical Interposer.

POET Technologies Inc. (PTK) is down 2.13 per cent on the day, trading at C$3.68 per share at 2:30 pm ET.


More From The Market Online

Market Open: Amazon and Alphabet plunge, Cohere set to scale | Oct 30

TSX futures slipped before Friday's market open, with investors digesting the fallout of the Bank of Canada's rate hike on Wednesday.

Elton Resources completes $3.47 million flow-through financing

Elton Resources completed a $3.47 million flow-through unit private placement, issuing 15.78 million units; final TSX Venture Exchange approval pending.

Small-cap Canadian healthcare firm expands AI-screening at home and abroad

Diagnos (TSXV:ADK) uses AI through its CARA platform to help detect eye diseases like diabetic retinopathy & age-related macular degeneration

@ the Bell: A nightmare on Wall Street

Canada’s benchmark stock index ended lower on Friday, weighed down by weakness in the technology and...